Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Aug 15, 2016 $6.12 $6.35 $5.95 $6.01 56 000
Aug 12, 2016 $6.15 $6.29 $6.12 $6.15 16 400
Aug 11, 2016 $6.25 $6.34 $6.14 $6.21 25 700
Aug 10, 2016 $6.20 $6.39 $6.12 $6.29 40 600
Aug 09, 2016 $6.15 $6.37 $6.08 $6.14 62 300
Aug 08, 2016 $6.24 $6.29 $5.88 $6.22 31 900
Aug 05, 2016 $6.42 $6.42 $6.25 $6.25 49 800
Aug 04, 2016 $6.18 $6.50 $6.16 $6.31 94 400
Aug 03, 2016 $5.90 $6.14 $5.82 $6.14 49 500
Aug 02, 2016 $6.00 $6.00 $5.74 $5.85 38 100
Aug 01, 2016 $5.48 $6.15 $5.48 $5.70 86 600
Jul 29, 2016 $5.58 $5.60 $5.27 $5.54 70 500
Jul 28, 2016 $5.60 $6.00 $4.41 $5.46 166 200
Jul 27, 2016 $0.580 $0.590 $0.520 $5.20 252 400
Jul 26, 2016 $0.580 $0.590 $0.550 $5.80 17 500
Jul 25, 2016 $0.570 $0.570 $0.510 $5.40 23 400
Jul 22, 2016 $0.550 $0.570 $0.520 $5.50 5 800
Jul 21, 2016 $0.560 $0.570 $0.530 $5.50 5 300
Jul 20, 2016 $0.550 $0.570 $0.530 $5.40 7 200
Jul 19, 2016 $0.560 $0.570 $0.550 $5.50 13 100
Jul 18, 2016 $0.590 $0.640 $0.550 $5.80 6 300
Jul 15, 2016 $0.590 $0.600 $0.590 $5.90 7 600
Jul 14, 2016 $0.570 $0.590 $0.570 $5.80 12 300
Jul 13, 2016 $0.550 $0.570 $0.550 $5.70 3 000
Jul 12, 2016 $0.570 $0.610 $0.560 $5.70 4 700
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT